Contact Us

Contact Us

Related Links

Site Map

HOME

 

Invitrx™

Invitrx CSS™ (Composite Skin Substitute)
Autologous | Allogeneous

Invitra CSS, Invitrx’s skin graft product, is not currently available for commercial use in the United States. Invitra CSS is available in other world markets outside of the USA, and is currently under investigation at a number of clinical research sites to eventually gain FDA approval for marketing in the USA. Click here to see dramatic photos from Clinical Trials in Civil Hospital (Guadalajara, Mexico).

Invitrx OC

Competitive Information
See how Invitrx's products compare with the competitions'

Reimbursement Information

Logistics

Frequently Asked Questions

Products in Pipeline

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Invitrx CSS™ - Autologous
Starts with a biopsy of healthy skin that can range from the size of a punch biopsy to the size of a postage stamp. The dermal and epidermal sheets are separated, isolated and grown separately. A dermal matrix is formed by the fibroblasts, supported by collagen and Vicryl mesh. Invitrx CSS, a 3-dimensional skin graft, is completed by the addition of keratinocytes on top of the dermal matrix. Each graft is custom made and designed to fit the size of the wound with the average graft being the size of a playing card (5 X 5cm). The grafts are personally delivered via our medical staff providing our clients and patients with the highest cellular viability possible thereby increasing graft take and wound closure.

Invitra CSS, Invitrx’s skin graft product, is not currently available for commercial use in the United States. Invitra CSS is available in other world markets outside of the USA, and is currently under investigation at a number of clinical research sites to eventually gain FDA approval for marketing in the USA.

Invitrx CSS™ Chronic Wound Applications
Here at Invitrx we believe that our service is just as important as the quality of our
product. We understand that the viability of the grafts delivered to our clients is critical, therefore Invitrx excels at providing high viability products that are coupled with close follow-up care that facilitates optimum graft take. Our sales and service departments help instruct hospital personnel and patients to ensure optimal success of each transplanted graft.

  • With a small punch biopsy Invitrx can construct a custom graft to fit your patients needs.
  • Invitrx is a licensed tissue bank, therefore we can store patient cells if more grafts are needed for future procedures.
  • Invitrx CSS is the only 3-dimensional autologous composite skin substitute.

Clinical studies have shown CSS offer reductions in morbidity and mortality for
the treatment of burns and chronic wounds, and for cutaneous reconstruction1.


Photo of of Invitrx CSS sample

Invitrx CSS™ Burn Victim Applications
At Invitrx we have a special passion for the burn victim community. Invitrx CSS was
first developed for this very reason, to provide a safe and effective way to treat burn victims. With Invitrx CSS, there is no need for patients to go through the traumatizing procedures for split-thickness skin grafts and because Invitrx CSS is autologous, there is no issue of autoimmune rejection.

The requirement for harvesting of donor skin for CSS was less than for conventional skin autografts. These results suggest that acute-phase recovery of patients with extensive burns is facilitated and that complications are reduced by the use of CSS together with conventional skin grafting2.

With a biopsy the size of a postage stamp, Invitrx can grow enough skin to cover a
severely burned patient and deliver it to the attending physician ready for transplant in three to six weeks.

DISCLAIMER: Invitra CSS, Invitrx’s skin graft product, is not currently available for commercial use in the United States. Invitra CSS is available in other world markets outside of the USA, and is currently under investigation at a number of clinical research sites to eventually gain FDA approval for marketing in the USA.

back to Invitrx CSS

 

Invitrx CSS™ - Allogeneous

Invitrx CSS™ Chronic Wound Applications
Here at Invitrx we believe that our service is just as important as the quality of our
product. We understand that the viability of the grafts delivered to our clients is critical, therefore Invitrx excels at providing high viability products that are coupled with close follow-up care that facilitates optimum graft take. Our sales and service departments help instruct hospital personnel and patients to ensure optimal success of each transplanted graft.

  • With a small punch biopsy Invitrx can construct a custom graft to fit your patients needs.
  • Invitrx is a licensed tissue bank, therefore we can store patient cells if more grafts are needed for future procedures.
  • Invitrx CSS is the only 3-dimensional autologous composite skin substitute.

Clinical studies have shown CSS offer reductions in morbidity and mortality for
the treatment of burns and chronic wounds, and for cutaneous reconstruction1.


Photo of of Invitrx CSS sample

Invitrx CSS™ Burn Victim Applications
At Invitrx we have a special passion for the burn victim community. Invitrx CSS was
first developed for this very reason, to provide a safe and effective way to treat burn victims. With Invitrx CSS, there is no need for patients to go through the traumatizing procedures for split-thickness skin grafts and because Invitrx CSS is autologous, there is no issue of autoimmune rejection.

The requirement for harvesting of donor skin for CSS was less than for conventional skin autografts. These results suggest that acute-phase recovery of patients with extensive burns is facilitated and that complications are reduced by the use of CSS together with conventional skin grafting2.

With a biopsy the size of a postage stamp, Invitrx can grow enough skin to cover a
severely burned patient and deliver it to the attending physician ready for transplant in three to six weeks.

DISCLAIMER: Invitra CSS, Invitrx’s skin graft product, is not currently available for commercial use in the United States. Invitra CSS is available in other world markets outside of the USA, and is currently under investigation at a number of clinical research sites to eventually gain FDA approval for marketing in the USA.

back to Invitrx CSS

 

Invitrx OC™
Restores sight by dramatically improving the visual acuity in patients with ocular surface disorders. Used for corneal grafts to treat ocular surface diseases.

Invitrx OC™ Corneal Staining

back to top

 

Competitve Advantage
We are the only company to provide a 3-D skin model for the burn and chronic wound markets.

Advantages:

  • Autologous: no rejection or chronic medications needed means better patient care
  • High cell viability: local delivery allows immediate healing and integration resulting in reduced hospital stays
  • Post-Op follow-up: patient care though assisting physician and nursing staff

The chart below illustrates the advantages of Invitrx products compared to similar products from other companies.
Competitive Matrix

Clinical Benefits:

  • Faster and more complete wound closure with an increased chance of survival for burn victims treated with composite skin substitutes (CSS)
  • Treatments with CSS can reduce the risk of amputations in patients with chronic and non-healing wounds.
  • Invitrx OC™ is capable of restoring sight by dramatically improving the visual acuity in patients with ocular surface disorders.

back to top

 

Reimbursement Information

For reimbursement regarding our Invitrx™ product line, please contact us at:

877-INVITRX
Monday-Friday, 8am-5pm (PST)

back to top

 

Invitrx™ Process Outline - Autologous Products
The following consists of the general workflow of the InvitrxTM product lines offered by Invitrx, Inc.

  1. Specimen Kit Delivery: Set up an Invitrx™ Specimen Kit delivery date. Please call the Invitrx, Inc. at (877) 468-4879 or (949) 472-81922.
  2. Biopsy Pickup: An Invitrx, Inc. representative will transport the biopsy to our laboratory.
  3. Graft Delivery: A representative of Invitrx, Inc., will deliver the graft, at the scheduled time.
  4. Post Procedure and Follow-up: After the initial application of the graft, our laboratory staff will schedule a follow up appointment to access the status of the graft. Please feel free to call us with any technical help you may need before, during and after the graft application. We’ll be there for you and your patient

Invitrx™ Process Outline - Allogeneous Products
The following consists of the general workflow of the Invitrx™ product lines offered by Invitrx, Inc.

  1. Place an Order: The products are ready to go at any time, just call us at (877) 468-4879 to place an order.
  2. Graft Delivery: A representative of Invitrx, Inc., will deliver the graft, at the scheduled time.
  3. Post Procedure and Follow-up: After the initial application of the graft, our laboratory staff will schedule a follow up appointment to access the status of the graft. Please feel free to call us with any technical help you may need before, during and after the graft application. We’ll be there for you and your patient.

 

Invitrx Patient FAQ's

1. Where are my keratinocytes located? What about my fibroblasts?
Human skin is made up of two areas the dermis and epidermis. The outer layer called the epidermis is composed mainly of keratinocytes, while the dermis is composed mostly of fibroblasts and other connective tissue. By separating the two layers we can then effectively isolate each of the desired cell types.

2. How are these cell-types harvested?
The donor produces a punch biopsy, which is obtained by a member of our staff and driven to our nearest lab site.

3. How much tissue is needed from the patient in order to get a good yield of cells?
The amount of tissue needed for our product is insignificant when compared to current standard split thickness protocols to harvest autologous tissue.

4. Is the viability of the cells affected by the age of the donor?
The viability of certain cell types is affected by the passage of time. Usually younger cells are more healthy and reproductive than their older siblings.

5. What happens to cells that might be left over after my procedure?
We guarantee efficient and responsible use of your personal tissue while it is under our care. Secondly, we will accomplish this task through maintaining firm roots that strive to hold a new standard of GMP and QC.

6. Will my cells be used for research purposes?
Your cells will only be used to form custom grafts for your personal wound closure. If any cells remain in the lab, the donor will be notified and informed of our intentions. Also, Chronic wounds may require freezing a small stock that could be stored and thawed when needed months later.

7. Can the cells taken from my biopsy be used for only me? What about another family member?
Our products are autologous which means that the cells from our product are the same as the donor’s own cells. The family member should not use the graft constructed for you because of an exponentially higher chance for the graft to fail.

8. How long can our cell types remain in storage?
We believe that the cells will remain viable for at least 2.5 years in a standard liquid nitrogen cooler.

9. How can you be sure that the cells will be viable once frozen?
Our team has a lot of experience maintaining these cell populations and this direct knowledge is what we believe and implement when forming our standard protocols.

10. Where will they be stored?
The cells will all be stored at the Invitrx facility in Irvine, CA.

11. Will a blackout affect the stored keratinocytes and fibroblasts?
Since the storage system for our patient cells is kept cool by liquid nitrogen, a loss of electricity would not effect the system.

12. How long will you maintain my cells?
Our team is dedicated to closing wounds and we will not stop until your wounds have closed entirely and the healing process can resume.

13. How can I get technical support?
Just fill out our tech support form and a support person will contact you to help you with any questions or difficulties you may have.

back to top

 

Products in Pipeline

  • Cell-based dry-eye formulation is currently undergoing clinical trials at the University of Sao Paolo Dept. of Ophthalmology.
  • Anti-aging, anti-wrinkle cream under development.

back to top